Please visit us at ACR 2010
November 8-10, 2010
Georgria World Congress Center
Atlanta, Georgia
Exhibit Number: 1736

The deadline to submit proposals for EULAR is September 7.

 

The Consortium of Rheumatology Researchers of North America, Inc. (CORRONA) was founded in 2000 by leading rheumatologists dedicated to advancing and improving the care of patients with rheumatic diseases.

CORRONA's mission is to advance rheumatology research and improve the quality of rheumatology patient care. CORRONA is an independent registry without any ownership links to the pharmaceutical industry.

photo

Welcome to CORRONA

The Consortium of Rheumatology Researchers of North America, Inc. (CORRONA) was founded in 2000 by leading rheumatologists dedicated to advancing and improving the care of patients with rheumatic diseases. CORRONA's mission is to advance rheumatology research and improve the quality of rheumatology patient care. CORRONA is an independent registry without any ownership links to the pharmaceutical industry. It is run by a group of experienced academic and clinical rheumatologists throughout the country with a wide range of experience (see CORRONA Leadership link).

Data on Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Osteoporosis, and Osteoporosis Risk derived from rheumatologists and patients are entered from the site where the physician saw the patient. The data are entered in the aggregate from around the United States and can then be analyzed by members of the CORRONA team. Data from the CORRONA registry can be used to derive insights regarding the effectiveness, and safety of drugs used to treat these diseases. It can also be used for the purposes of improved patient care and quality management.

 
 

HOME | ABOUT CORRONA | PROGRAMS | FAQ/COMPANY POLICIES | PRIVACY POLICY | LEGAL | CONTACT US

© 2009 CORRONA, Inc. All Rights Reserved.